Bibliometric analysis of childhood-onset systemic lupus erythematosus from 2000 to 2022

Lupus. 2024 Apr;33(4):387-396. doi: 10.1177/09612033241230586. Epub 2024 Feb 2.

Abstract

Background: Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disorder. When SLE occurs in individuals under the age of 18, it is referred to as childhood-onset SLE (cSLE). Currently, there is a dearth of bibliometric research pertaining to cSLE.

Method: Relevant studies in the field of cSLE from 2000 to 2022 were screened from the Web of Science Core Collection (WoSCC). CiteSpace and VOSviewer software were used to visualize the annual publications, countries, institutions, authors, journals, keywords, and references, after which the authors conducted the scientific analysis.

Results: A total of 2857 articles were included in this study, and the number of articles published in the past 20 years showed an overall upwards trend. The most prolific countries are the United States, China, and Brazil; however, the United States, Canada, and the United Kingdom are clearly superior in terms of literary influence, and there is more cooperation between them and their institutions. LUPUS (n = 389) contributed the most to the variance. Brunner, HI's contribution in the field of cSLE is outstanding. The words related to 'lupus nephritis' and 'antibodies' are important words reflected in the keyword network diagram. The keywords included 'evidence-based recommendation', 'validation', 'diagnosis' and 'adult' from 2019, and 'continuous bursts' to the present.

Conclusion: This study examined the research status of cSLE patients, discussed and analysed the research hotspots and trends in this field, and provided a reference for further research in this field to promote the development of cSLE research.

Keywords: Bibliometric analysis; CiteSpace; VOSviewer; Web of Science; altmetric analysis; childhood-onset systemic lupus erythematosus; visual analysis.

MeSH terms

  • Antibodies
  • Bibliometrics
  • Brazil
  • Humans
  • Lupus Erythematosus, Systemic* / diagnosis
  • Lupus Nephritis*

Substances

  • Antibodies